Price T Rowe Associates Inc Mannkind Corp Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Mannkind Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 267,940 shares of MNKD stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267,940
Previous 241,096 11.13%
Holding current value
$1.36 Million
Previous $902,000 59.53%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$3.42 - $5.74 $91,806 - $154,084
26,844 Added 11.13%
267,940 $1.44 Million
Q2 2025

Aug 14, 2025
BUY
$3.71 - $5.04 $147,580 - $200,486
39,779 Added 19.76%
241,096 $902,000
Q1 2025

May 14, 2025
BUY
$4.92 - $6.6 $129,435 - $173,632
26,308 Added 15.03%
201,317 $1.01 Million
Q4 2024

Feb 14, 2025
BUY
$5.93 - $7.44 $111,519 - $139,916
18,806 Added 12.04%
175,009 $1.13 Million
Q3 2024

Nov 14, 2024
SELL
$5.01 - $6.7 $172,629 - $230,861
-34,457 Reduced 18.07%
156,203 $983,000
Q2 2024

Aug 14, 2024
BUY
$4.05 - $5.43 $75,354 - $101,030
18,606 Added 10.81%
190,660 $996,000
Q1 2024

May 15, 2024
BUY
$3.25 - $5.27 $30,582 - $49,590
9,410 Added 5.79%
172,054 $780,000
Q4 2023

Feb 14, 2024
BUY
$3.34 - $4.29 $171,402 - $220,154
51,318 Added 46.1%
162,644 $593,000
Q3 2023

Nov 14, 2023
SELL
$3.91 - $5.45 $131,160 - $182,820
-33,545 Reduced 23.16%
111,326 $460,000
Q2 2023

Aug 14, 2023
BUY
$3.72 - $4.79 $39,934 - $51,420
10,735 Added 8.0%
144,871 $590,000
Q1 2023

May 15, 2023
SELL
$3.95 - $5.63 $17,498 - $24,940
-4,430 Reduced 3.2%
134,136 $550,000
Q4 2022

Feb 14, 2023
BUY
$3.02 - $5.37 $16,223 - $28,847
5,372 Added 4.03%
138,566 $730,000
Q3 2022

Nov 14, 2022
BUY
$2.99 - $4.35 $44,631 - $64,932
14,927 Added 12.62%
133,194 $412,000
Q2 2022

Aug 15, 2022
BUY
$2.67 - $4.77 $17,491 - $31,248
6,551 Added 5.86%
118,267 $451,000
Q1 2022

May 16, 2022
BUY
$2.62 - $4.45 $48,797 - $82,881
18,625 Added 20.01%
111,716 $411,000
Q4 2021

Feb 14, 2022
SELL
$4.05 - $5.37 $19,853 - $26,323
-4,902 Reduced 5.0%
93,091 $407,000
Q3 2021

Nov 15, 2021
BUY
$3.89 - $5.48 $1,167 - $1,644
300 Added 0.31%
97,993 $426,000
Q2 2021

Aug 16, 2021
BUY
$3.61 - $5.45 $21,609 - $32,623
5,986 Added 6.53%
97,693 $532,000
Q1 2021

May 17, 2021
BUY
$3.14 - $6.14 $157,593 - $308,160
50,189 Added 120.88%
91,707 $359,000
Q4 2020

Feb 16, 2021
BUY
$1.79 - $4.04 $74,317 - $167,732
41,518 New
41,518 $130,000

Others Institutions Holding MNKD

# of Institutions
258
Shares Held
165M
Call Options Held
2.76M
Put Options Held
689K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.3B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email